Population Pharmacokinetics of Amoxicillin in Term Neonates Undergoing Moderate Hypothermia
for the PharmaCool Study Group
(2018) Clinical Pharmacology & Therapeutics, volume 103, issue 3, pp. 458 - 467
(Article)
Abstract
The pharmacokinetics (PK) of amoxicillin in asphyxiated newborns undergoing moderate hypothermia were quantified using prospective data (N = 125). The population PK was described by a 2-compartment model with a priori birthweight (BW) based allometric scaling. Significant correlations were observed between clearance (Cl) and postnatal age (PNA), gestational age (GA),
... read more
body temperature (TEMP), and urine output (UO). For a typical patient with GA 40 weeks, BW 3,000 g, 2 days PNA (i.e., TEMP 33.5°C), and normal UO, Cl was 0.26 L/h (interindividual variability (IIV) 41.9%) and volume of distribution of the central compartment was 0.34 L/kg (IIV of 114.6%). For this patient, Cl increased to 0.41 L/h at PNA 5 days and TEMP 37.0°C. The respective contributions of both covariates were 23% and 27%. Based on Monte Carlo simulations we recommend 50 and 75 mg/kg/24h amoxicillin in three doses for patients with GA 36–37 and 38–42 weeks, respectively.
show less
Keywords: Aging/metabolism, Algorithms, Amoxicillin/administration & dosage, Anti-Bacterial Agents/administration & dosage, Birth Weight, Body Temperature, Cohort Studies, Computer Simulation, Female, Gestational Age, Humans, Hypothermia/metabolism, Infant, Newborn, Male, Monte Carlo Method, Prospective Studies, Urodynamics, Pharmacology, Pharmacology (medical), Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
ISSN: 0009-9236
Publisher: Nature Publishing Group
Note: Funding Information: Collaborators of the PharmaCool study group are: Mieke J. Brouwer, Marcel P. van den Broek, Carin M.A. Rademaker, Djien Liem, Katerina Steiner, Rogier C.J. de Jonge, Annelies A. Bos, S.M. Mulder-de Tollenaer, L.J.M. Groot Jebbink-Akkerman, Michel Sonnaert, Fleur Anne Camfferman. Funding for this study was received from the Dutch Government (ZonMw Grant number: 40-41500-98-9002). The authors thank Irmgard Corten of the Clinical Research Unit (CRU) of the Academic Medical Center (CRU) for contributions with regard to data management. Publisher Copyright: © 2017 American Society for Clinical Pharmacology and Therapeutics
(Peer reviewed)